Skip to main content
Gut logoLink to Gut
. 1998 Jul;43(Suppl 1):S33–S34. doi: 10.1136/gut.43.2008.s33

Helicobacter pylori: the gastric cancer problem

D Forman
PMCID: PMC1766599  PMID: 9764037

Full Text

The Full Text of this article is available as a PDF (64.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beales I. L., Davey N. J., Pusey C. D., Lechler R. I., Calam J. Long-term sequelae of Helicobacter pylori gastritis. Lancet. 1995 Aug 5;346(8971):381–382. doi: 10.1016/s0140-6736(95)92263-6. [DOI] [PubMed] [Google Scholar]
  2. Blaser M. J., Perez-Perez G. I., Kleanthous H., Cover T. L., Peek R. M., Chyou P. H., Stemmermann G. N., Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995 May 15;55(10):2111–2115. [PubMed] [Google Scholar]
  3. Chow W. H., Blaser M. J., Blot W. J., Gammon M. D., Vaughan T. L., Risch H. A., Perez-Perez G. I., Schoenberg J. B., Stanford J. L., Rotterdam H. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 1998 Feb 15;58(4):588–590. [PubMed] [Google Scholar]
  4. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992 Dec 15;52(24):6735–6740. [PubMed] [Google Scholar]
  5. Forman D., Sitas F., Newell D. G., Stacey A. R., Boreham J., Peto R., Campbell T. C., Li J., Chen J. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer. 1990 Oct 15;46(4):608–611. doi: 10.1002/ijc.2910460410. [DOI] [PubMed] [Google Scholar]
  6. Forman D. The prevalence of Helicobacter pylori infection in gastric cancer. Aliment Pharmacol Ther. 1995;9 (Suppl 2):71–76. [PubMed] [Google Scholar]
  7. Goldstone A. R., Quirke P., Dixon M. F. Helicobacter pylori infection and gastric cancer. J Pathol. 1996 Jun;179(2):129–137. doi: 10.1002/(SICI)1096-9896(199606)179:2<129::AID-PATH504>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]
  8. Goodman K. J., Correa P., Tenganá Aux H. J., DeLany J. P., Collazos T. Nutritional factors and Helicobacter pylori infection in Colombian children. J Pediatr Gastroenterol Nutr. 1997 Nov;25(5):507–515. doi: 10.1097/00005176-199711000-00004. [DOI] [PubMed] [Google Scholar]
  9. Goodman K. J., Correa P. The transmission of Helicobacter pylori. A critical review of the evidence. Int J Epidemiol. 1995 Oct;24(5):875–887. doi: 10.1093/ije/24.5.875. [DOI] [PubMed] [Google Scholar]
  10. Kuipers E. J., Pérez-Pérez G. I., Meuwissen S. G., Blaser M. J. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst. 1995 Dec 6;87(23):1777–1780. doi: 10.1093/jnci/87.23.1777. [DOI] [PubMed] [Google Scholar]
  11. Kuipers E. J., Uyterlinde A. M., Peña A. S., Roosendaal R., Pals G., Nelis G. F., Festen H. P., Meuwissen S. G. Long-term sequelae of Helicobacter pylori gastritis. Lancet. 1995 Jun 17;345(8964):1525–1528. doi: 10.1016/s0140-6736(95)91084-0. [DOI] [PubMed] [Google Scholar]
  12. Labenz J., Blum A. L., Bayerdörffer E., Meining A., Stolte M., Börsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology. 1997 May;112(5):1442–1447. doi: 10.1016/s0016-5085(97)70024-6. [DOI] [PubMed] [Google Scholar]
  13. Murray C. J., Lopez A. D. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997 May 3;349(9061):1269–1276. doi: 10.1016/S0140-6736(96)07493-4. [DOI] [PubMed] [Google Scholar]
  14. Parsonnet J., Friedman G. D., Orentreich N., Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 1997 Mar;40(3):297–301. doi: 10.1136/gut.40.3.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Parsonnet J., Harris R. A., Hack H. M., Owens D. K. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet. 1996 Jul 20;348(9021):150–154. doi: 10.1016/s0140-6736(96)01501-2. [DOI] [PubMed] [Google Scholar]
  16. Uemura N., Mukai T., Okamoto S., Yamaguchi S., Mashiba H., Taniyama K., Sasaki N., Haruma K., Sumii K., Kajiyama G. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev. 1997 Aug;6(8):639–642. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES